138 related articles for article (PubMed ID: 1376846)
1. Effects of isradipine on hypertension and renal hemodynamics.
Siamopoulos KC; Elisaf M; Dardamanis M; Sferopoulos G; Pappas M
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S87-9. PubMed ID: 1376846
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term administration of isradipine on renal hemodynamics and sodium metabolism.
Francischetti EA; Barroso I; da Silva A; Fagundes VG
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S90-2. PubMed ID: 1376847
[TBL] [Abstract][Full Text] [Related]
3. Long-term antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.
Wittenberg C; Rosenfeld JB
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S93-5. PubMed ID: 1376848
[TBL] [Abstract][Full Text] [Related]
4. Metabolic, hematological, and cardiac effects of long-term isradipine treatment in mild-to-moderate essential hypertension.
Meriç M; Gören T; Atilgan D; Eren N; Cubukçu A; Koylan N
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S58-60. PubMed ID: 1376837
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and tolerability of isradipine in the treatment of mild-to-moderate hypertension in young and elderly patients.
Batlouni M; Armaganijan D; Ghorayeb N; Magliano MF
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S53-7. PubMed ID: 1376836
[TBL] [Abstract][Full Text] [Related]
6. Isradipine in the treatment of mild-to-moderate hypertension in Portugal.
Pereira-Miguel JM; Correa-Nunes A; Rocha-Gonçalves F; Mariano-Pego G
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S49-52. PubMed ID: 1376835
[TBL] [Abstract][Full Text] [Related]
7. Isradipine, a new calcium antagonist: effects on maternal and fetal hemodynamics.
Lunell NO; Garoff L; Grunewald C; Nisell H; Nylund L; Sarby B; Thornström S
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S37-40. PubMed ID: 1720484
[TBL] [Abstract][Full Text] [Related]
8. First clinical experience with isradipine in the treatment of hypertension in Portugal.
Rocha-Gonçalves F; Mariano-Pego G; Viegas J; Correia JM; Botelho MA
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485
[TBL] [Abstract][Full Text] [Related]
9. Effects of the calcium antagonist isradipine on 24-hour ambulatory blood pressure, platelet aggregation, and neutrophil oxygen free radicals in hypertension.
Ding YA; Han CL; Chou TC; Lai WY; Shiao MF
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S32-7. PubMed ID: 1376832
[TBL] [Abstract][Full Text] [Related]
10. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin.
Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303
[TBL] [Abstract][Full Text] [Related]
12. Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension Society.
Lüscher TF; Waeber B
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S1-3. PubMed ID: 1720476
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
Fitscha P; Meisner W; Hitzenberger G
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
[TBL] [Abstract][Full Text] [Related]
14. Regression of cardiac hypertrophy in hypertensive patients by long-term treatment with isradipine.
Török E; Borbás S; Lengyel M; Zorándi A
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S79-83. PubMed ID: 1376844
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of isradipine in the treatment of mild-to-moderate hypertension in general practice: a large-scale surveillance study.
Hermans L; Bogaert M; Degaute JP; Rorive G; Six R; Bara L; Lanssiers P; De Keyser P; Westelinck KJ
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S38-45. PubMed ID: 1376833
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological modulation of stress-induced cardiovascular hyperreactivity in essential hypertension.
Schulte W; Rüddel H; Schmieder R; Schächinger H; Bräutigam M; Welzel D
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S70-3. PubMed ID: 1376841
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of nitrendipine monotherapy in essential hypertension.
Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
[TBL] [Abstract][Full Text] [Related]
18. Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group.
Jern S; Hansson L; Scherstén B; Kullman S; Sörensen S; Dahlöf B; Eggertsen R; Sivertsson R
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S7-8. PubMed ID: 1720487
[TBL] [Abstract][Full Text] [Related]
19. Long-term (2-year) isradipine data in the treatment of mild-to-moderate hypertension.
D'Hont G; Meurant JP; Clement DL; Rorive G; Hermans L; De Keyser P; Westelinck KJ
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S46-8. PubMed ID: 1376834
[TBL] [Abstract][Full Text] [Related]
20. Effects of isradipine on renal hemodynamics in renal transplant patients treated with cyclosporine.
Ahmed K; Michael B; Burke JF
Clin Nephrol; 1997 Nov; 48(5):307-10. PubMed ID: 9403215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
